Arcutis Biotherapeutics Inc (ARQT)

Arcutis Biotherapeutics Inc Azioni (ARQT) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	64.51% 13.53	38.11	5.19	2.781	2.961
Operating Expenses	7.07% 69.71	75.01	71.95	79.05	71.39
Interest Income/Expense	2.69% 7.762	7.559	7.349	7.042	6.915
Benefits Costs and Expenses	300.71	-	-	-	-
Costs And Expenses	0.42% 74.69	75.01	71.95	79.05	71.39
Operating Income/Loss	65.75% -61.17	-36.90	-66.76	-76.27	-68.42
Income/Loss From Continuing Operations Before Tax	853.58% -287.18	38.11	-70.99	-80.10	2.961
Income Tax Expense/Benefit	99.17% 0.025	3.023	-	-	-
Income/Loss From Continuing Operations After Tax	48.07% -66.28	-44.77	-70.99	-80.10	-72.02
Net Income/Loss	48.07% -66.28	-44.77	-70.99	-80.10	-72.02
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	87.29% 7.8435	61.73	61.43	61.17	2.0033
Diluted Average Shares	87.29% 7.8435	61.73	61.43	61.17	2.0033
Basic Earnings Per Share	19.18% -0.59	-0.73	-1.16	-1.31	-1.14
Diluted Earnings Per Share	19.18% -0.59	-0.73	-1.16	-1.31	-1.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-